期刊文献+

青年女性三阴乳腺癌的MRI表现 被引量:2

MRI characteristics of triple negative breast cancer in young women
下载PDF
导出
摘要 目的:探讨青年女性(年龄<35岁)三阴乳腺癌的MRI特征。方法:搜集病理及免疫组化证实为女性三阴乳腺癌患者(<35岁)16例术前MRI检查资料,分析MRI征象。结果:16例病灶均为肿块型,其中11例为单发病灶,5例为多发病灶;圆形3例,椭圆形7例,不规则形6例;4例边缘光整,10例边缘不规则,2例边缘见毛刺;不均匀强化10例,边缘强化6例;平扫T2WI图像等信号3例,稍高信号9例,高信号4例;DWI 16例均为高信号,其中5例为环形高信号;平扫T2WI图像上7例可见明显高信号;TIC曲线:Ⅱ型9例,Ⅲ型7例。结论:青年女性三阴乳腺癌的MRI表现有一定特征性。 Objective:To evaluate the MRI characteristics of triple negative breast cancer in young women (age 35). Methods:Preoperative MRI data of triple negative breast cancer in 16 young women (age 〈35 years) confirmed by pathology and immunohistochemistry were collected and analyzed. Results:There were mass-like lesions in all 16 cases. There was single lesion in 11 cases and multiple lesions in 5 cases. The lesions were round in 3 cases,oval in 7 cases and irregular in 6 cases. The margins were well-defined in 4 cases,irregular in 10 cases and spiculated in 2 cases. After contrast injection, there was heterogeneous enhancement in 10 cases and rim enhancement in 6 cases. On T2WI,3 cases showed equal signal intensity, 9 cases showed slightly high signal intensity and 4 cases showed high signal intensity. All 16 cases showed high signal intensity on DWI and 5 of 16 cases showed ring-like high intensity. On TIC curve,it showed type IT in 9 cases and Type Ⅲ in 7 cases. Conclusion:There are cerain MRI characteristics in triple negative breast cancer of young women.
出处 《放射学实践》 北大核心 2017年第6期566-568,共3页 Radiologic Practice
基金 辽宁省自然科学基金(2015020279) 国家公益性行业科研专项(201402020)
关键词 磁共振成像 乳腺肿瘤 女性 Magnetic resonance imaging Breast neoplasms Femininity
  • 相关文献

参考文献9

二级参考文献97

  • 1安松林,方志沂,于泳.青年乳腺癌的临床特点及预后[J].实用癌症杂志,2005,20(6):639-642. 被引量:14
  • 2邬玉辉,何英,唐利立.青年期女性乳腺癌临床病理分析[J].实用预防医学,2006,13(3):545-547. 被引量:8
  • 3WOLFF A C,HAMMOND M E,SCHWARTZ J N. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer[J].Journal of Clinical Oncology,2007,(01):118-145.
  • 4SEKINE I,SHIMIZU C,NISHIO K. A literature review of molecular markers predictive of clinical response to cytotoxic chemotherapy in patients with breast cancer[J].International Journal of Clinical Oncology,2009,(02):112-119.
  • 5LIGRESTI G,LIBRA M,MILITELLO L. Breast cancer:molecular basis and therapeutic strategies (review)[J].Mol Med Rep,2008,(04):451-458.
  • 6UEMATSU T,KASAMI M,YUEN S. Triplenegative breast cancer:correlation between MR imaging and pathologic findings[J].Radiology,2009,(03):638-647.doi:10.1148/radiol.2503081054.
  • 7KO E S,LEE B H,KIM H A. Triple-negative breast cancer:correlation between imaging and pathological findings[J].European Journal of Radiology,2010,(05):1111-1117.
  • 8IRSHAD S,ELLIS P,TUTT A. Molecular heterogeneity of triple-negative breast cancer and its clinical implications[J].Current Opinion in Oncology,2011,(06):566-577.
  • 9MONTAGNA E,MAISONNEUVE P,ROTMENSZ N. Heterogeneity of triple-negative breast cancer:histologic subtyping to inform the outcome[J].Clinical Breast Cancer,2013,(01):31-39.
  • 10DELPECH Y,WU Y,HESS K R. Ki67 expression in the primary tumor predicts for clinical benefit and time to progression on first-line endocrine therapy in estrogen receptor-positive metastatic breast cancer[J].Breast Cancer Research and Treatment,2012,(02):619-627.

共引文献97

同被引文献19

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部